• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Virtus Biotech Clinical Trials ETF (NY:BBC)

    45.15 -0.63 (-1.39%)
    Official Closing Price Updated: 8:00 PM EDT, Sep 25, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 32,343
    Open 46.18
    Bid (Size) 17.00 (100)
    Ask (Size) 45.35 (100)
    Prev. Close 45.78
    Today's Range 44.95 - 46.29
    52wk Range 25.59 - 56.18
    Shares Outstanding 4,000
    Dividend Yield 1.45%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Venture Into High-Volatility Corners of the Market With These 3 ETFs ↗
    BBC, IWC and GDXJ offer diversified exposure to clinical-stage biotech, micro-cap stocks and junior gold miners, high-risk sectors that have posted strong year-to-date gains in 2026. 
    Via MarketBeat
    Topics ETFs
    News headline image
    Innovative ETF Strategies That Are Paying Off This Summer ↗
    Amid record ETF inflows, niche funds like BBC, LATR, and FMED offer targeted exposure to biotech trials, buy-now-pay-later firms, and disruptive medicine, with notable recent returns. 
    Via MarketBeat
    Topics ETFs

    Performance

    YTD
    +20.0%
    +20.0%
    1 Month
    -18.1%
    -18.1%
    3 Month
    -11.6%
    -11.6%
    6 Month
    +14.1%
    +14.1%
    1 Year
    +76.0%
    +76.0%

    More News

    Read More
    News headline image
    Why Did NGNE Stock Surge 25% In Pre-Market Today? ↗
    Via Stocktwits
    ABUS Stock On Track For Biggest Intraday Drop In Over 5 Years – What’s The Issue Around Its Patent In Europe? ↗
    Via Stocktwits
    Topics Intellectual Property
    GLUE Stock Slips Pre-Market After Pricing $300 Million Public Offer At Discount ↗
    Via Stocktwits
    News headline image
    Why Did UPB Stock Pop 20% In Pre-Market Today? ↗
    Via Stocktwits
    News headline image
    Why Did GLUE Stock Surge Over 50% In Premarket Today? ↗
    Via Stocktwits
    News headline image
    Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation ↗
    Via Benzinga
    News headline image
    ETFs Last Week: Funds Lead The Charge As Markets Stage A Return To Risk-On ↗
    Via Benzinga
    Topics ETFs Economy Stocks
    News headline image
    CureVac Stock Declines On Weaker-Than-Expected Q4 Revenue: Retail’s On Wait-And-Watch Mode ↗
    Via Stocktwits
    Topics Government
    News headline image
    Why Is uniQure Stock Skyrocketing On Tuesday? ↗
    Via Benzinga
    News headline image
    Inflation Cools In June, Triggers Spike In Laggard ETFs ↗
    Via Talk Markets
    Topics ETFs Economy
    News headline image
    5 ETFs Riding High On The Biotech Comeback ↗
    Via Talk Markets
    News headline image
    Biotech ETF Tops in June: 5 Stocks That Outperform ↗
    Via Talk Markets
    News headline image
    4 Sector ETFs That Survived Market Turmoil in June ↗
    Via Talk Markets

    Frequently Asked Questions

    Is Virtus Biotech Clinical Trials ETF publicly traded?
    Yes, Virtus Biotech Clinical Trials ETF is publicly traded.
    What exchange does Virtus Biotech Clinical Trials ETF trade on?
    Virtus Biotech Clinical Trials ETF trades on the New York Stock Exchange
    What is the ticker symbol for Virtus Biotech Clinical Trials ETF?
    The ticker symbol for Virtus Biotech Clinical Trials ETF is BBC on the New York Stock Exchange
    What is the current price of Virtus Biotech Clinical Trials ETF?
    The current price of Virtus Biotech Clinical Trials ETF is 45.15
    When was Virtus Biotech Clinical Trials ETF last traded?
    The last trade of Virtus Biotech Clinical Trials ETF was at 09/25/26 08:00 PM ET
    What is the market capitalization of Virtus Biotech Clinical Trials ETF?
    The market capitalization of Virtus Biotech Clinical Trials ETF is 180.58K
    How many shares of Virtus Biotech Clinical Trials ETF are outstanding?
    Virtus Biotech Clinical Trials ETF has 181K shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.